Alzheimer’s disease (AD) is a progressive brain disease and the 6th leading cause of death in the U.S. While symptoms of AD such as memory loss and impaired judgement are widely recognized, we know less about what the disease does to the brain. Science still has a long way to go when it comes to...
Early detection could be a powerful tool to manage Alzheimer’s. Early detection gives people time to try different medications or interventions that may slow the progression of Alzheimer's disease. We have reached the point where cognitive tests are able to detect early Alzheimer’s in people without symptoms. Show More Summary
Many of us have seen loved ones progress through a neurological disorder. First you notice changes in their speech patterns, then their walk becomes less stable, then they become slower overall. These conditions worsen as they progress through the disease. Show More Summary
How Common Is Alzheimer’s Disease In US? The most common type of dementia, Alzheimer’s disease affects about 5.5 million Americans of all ages, according to Alzheimer’s Association. It is a progressively debilitating disease that slowly affects memory and thinking skills. Alzheimer’s is the...
Alzheimer’s disease is the most common neurodegenerative problem in humans. It effectively destroys our memory and other important mental functions. Scientists believe that this progressive disease is primarily the result of amyloidShow More Summary
Like his father before him and millions of others, Ted Esau’s brain started to deteriorate in his late-50s. Plaque was building up. Part of his brain was starting to shrink. Although invisible to everyone including himself, the first stages of Alzheimer’s disease were beginning to take hold. But following a program of healthy eating, exercise, […]
The lack of tangible progress over the last fifteen years towards working therapies for Alzheimer's disease that are based on clearing amyloid has led to a great diversity of alternative thinking on the causes and pathology of the condition, as well as on other approaches to treatment. Show More Summary
The largest study of its type shows that a mutation in the gene coding for brain-derived neurotrophic factor may predict Alzheimer's disease progression.
Neuroinflammation is an essential process in the development and progression of several neurodegenerative diseases, including multiple sclerosis (MS), Alzheimer’s and Parkinson’s. Researchers from the University of North Carolina School...Show More Summary
Scientists at Queensland Brain Institute find noninvasive technique slows progression of Alzheimer’s disease in mice Australian researchers say they have made a promising step in the future treatment of Alzheimer’s disease after discovering ultrasound can effectively and safely deliver drugs to the damaged brain. Show More Summary
A new study has found that the metabolism of omega-3 and omega-6 unsaturated fatty acids in the brain are associated with the progression of Alzheimer's disease.
(King's College London) A new study published in PLOS Medicine's Special Issue on Dementia has found that the metabolism of omega-3 and omega-6 unsaturated fatty acids in the brain are associated with the progression of Alzheimer's disease.
Alzheimer's disease i s the only one of the top leading causes of death whose progression can't be slowed down or stopped. The neurodegenerative disease affects about 5.5 million Americans, a number that's expected to balloon to 13.8...Show More Summary
(PLOS) A new study of Alzheimer's disease by Fiona Kerr and Linda Partridge at University College London, uses mouse and fruit fly models to show that Keap1, which inhibits the protective protein Nrf2, is a promising target for new preventative drugs for Alzheimer's and other neurodegenerative diseases. Show More Summary
(Amplify Public Affairs) UsAgainstAlzheimer's, which works collaboratively with industry partners to see near- and long-term progress against this destructive disease, applauds the vast investment of Merck, the diligence of the manyShow More Summary
Not a single medicine has been shown to slow the progression of the disease, so researchers are taking an aggressive new approach.
Researchers have kept trying despite a 99 percent failure rate.
The progression of Alzheimer's disease, happening in the midst of aging in general, and often other unrelated neurodegeneration as well, is so complex and sweeping that every research group focuses down on just one part of the whole....Show More Summary
Findings from a recent study published in JAMA Psychiatry have found a link between delirium and the progression of Alzheimer’s disease. Delirium occurs when patients become confused and disoriented, and is prevalent in elderly patients. Show More Summary
(JCI Journals) In Alzheimer's disease and Parkinson's disease, loss of the sense of smell often precedes classical symptoms of cognitive or motor dysfunction. In work published this week in the JCI, a team led by Jacob Hooker at Harvard...Show More Summary